Chai Angels
New York, United States2
1M
2
0.50
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Preferences and restrictions
- Requirements for founders
- Female
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.50
- Investments by industry
- Cyber Security (1)
- Email (1)
- Enterprise Software (1)
- SaaS (1)
- Software (1) Show 8 more
- Investments by region
- United States (2)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| HacWare | 12 Apr 2022 | Software, SaaS, Enterprise Software, Software Engineering, Cyber Security, Email | Seed | 2M | United States, New York, New York |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Pelage Pharmaceuticals | Oct 15, 2025 | Biotechnology, Hair Loss Treatment, Hair Loss Treatments, Molecular and Stem Cell Biology, Regenerative Medicine, Stem Cell Biology | - | 120000000 USD | Los Angeles, California |
| Platter | Oct 3, 2025 | Ecommerce, ecommerce technology, Shopify, software, Software | Early stage | 1600000 USD | New York |
| Iantrek | Aug 20, 2025 | Glaucoma Management, Medical Technology, Ophthalmic Surgery | - | 42000000 USD | White Plains, New York |
| Lumachain | Oct 16, 2024 | AI supply chain platform, Computer Vision AI platform, traceability solution | - | - | .svg) Sydney, New South Wales |
| Re-Vana Therapeutics | Nov 30, 2022 | Drug Delivery, Ocular Therapeutics, Ophthalmic Therapeutics, Sustained Release Technology | Early stage | 11900000 USD |  Belfast, Northern Ireland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.